Tag: arvinas

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to arvinas

Arvinas (NASDAQ:ARVN) Coverage Initiated by Analysts at UBS Group

Added to Collection on: 2021-05-20 21:11:15

Tags for this article:

Financial markets
Finance
Financial economics
Stock market
Equity securities
Corporate finance
Stock
Short
Lithium
Initial public offering
Share
Price?earnings ratio
arvinas

Click the tags to see associated articles and topics

View Article Details
Arvinas (NASDAQ:ARVN) Price Target Raised to $170.00 at Truist

Added to Collection on: 2021-07-22 14:57:45

Tags for this article:

Finance
Money
Financial markets
Stock market
Equity securities
Financial ratios
Corporate finance
Stock
Share
Short
Price?earnings ratio
Rate of return
arvinas

Click the tags to see associated articles and topics

View Article Details
Pfizer funnels $1B into protein degrader Arvinas, with more in biobucks on the table

Added to Collection on: 2021-07-22 14:15:00

Tags for this article:

Branches of biology
Life Sciences
Biology
Biotechnology
Protein kinase inhibitors
Pharmacology
Proteolysis targeting chimera
Palbociclib
Metastatic breast cancer
Proteasome
Cyclin-dependent kinase 4
Molecular glue
Pfizer
arvinas

Click the tags to see associated articles and topics

View Article Details
Why Arvinas Jumped 10% Today

Added to Collection on: 2021-07-22 19:18:45

Tags for this article:

Health sciences
Life Sciences
Health care
Pfizer
Pharmaceutical industry
HER2/neu
arvinas
PFIZER'S

Click the tags to see associated articles and topics

View Article Details
Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader

Added to Collection on: 2021-07-23 10:52:30

Tags for this article:

Chemical compounds
Enzymes
Organic compounds
Protein kinase inhibitors
Breakthrough therapy
Piperazines
Aminopyridines
Lactams
Palbociclib
CDK inhibitor
Breast cancer
Cyclin-dependent kinase 4
Pfizer
arvinas

Click the tags to see associated articles and topics

View Article Details
Pfizer backs protein degrader drugs with Arvinas deal

Added to Collection on: 2021-07-30 14:37:30

Tags for this article:

Branches of biology
Biology
Life Sciences
Proteins
Posttranslational modification
Biotechnology
Craig M. Crews
Proteolysis targeting chimera
Proteasome
Ubiquitin
Palbociclib
Parkin
arvinas

Click the tags to see associated articles and topics

View Article Details
Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas

Added to Collection on: 2021-08-09 13:26:34

Tags for this article:

Articles
Academic disciplines
Cybernetics
Insilico Medicine
Proteolysis targeting chimera
Artificial intelligence
Machine learning
arvinas

Click the tags to see associated articles and topics

View Article Details
Letter to the editor: Building the next generation of leaders - New Haven Register

Added to Collection on: 2022-07-14 17:17:50

Tags for this article:

Articles
Education
Engineering education
Science education
New Haven, Connecticut
Science, technology, engineering, and mathematics
West Haven, Connecticut
Fair Haven, New Haven
arvinas

Click the tags to see associated articles and topics

View Article Details
Arvinas falls 17% after early-stage data for Pfizer-partnered tumor therapy - Seeking Alpha

Added to Collection on: 2023-01-09 19:48:22

Tags for this article:

Chemical compounds
Organic compounds
Branches of biology
Protein kinase inhibitors
Cell cycle
Cyclopentanes
Piperazines
Specialty drugs
Palbociclib
HER2/neu
Cyclin-dependent kinase
CDK inhibitor
Pfizer
arvinas

Click the tags to see associated articles and topics

View Article Details
PROTACs oncology market to reach $3.7 bn by 2030 despite regulatory challenges: GlobalData

Added to Collection on: 2024-06-04 14:32:39

Tags for this article:

Biotechnology
Chemical biology
Pharmacology
Proteolysis targeting chimera
Ubiquitin ligase
Targeted therapy
Craig M. Crews
arvinas
PFIZER'S

Click the tags to see associated articles and topics

View Article Details